Reactivation of systemic lupus erythematosus in a dialysis patient after tuberculous peritonitis

Lupus

Volumn 11, Issue 1, 2002, Pages 49-51

  Lui, S L ^a   Lam, M F ^a   Tse, K C ^a   Lo, W K ^a  

^a TUNG WAH HOSPITAL   (Hong Kong)

Author keywords

Dialysis; Lupus; Reactivation; Tuberculous peritonitis

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; FEMALE; HUMAN; IMMUNOPATHOGENESIS; KIDNEY FAILURE; LUPUS ERYTHEMATOSUS NEPHRITIS; PRIORITY JOURNAL; RECURRENT DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; TUBERCULOUS PERITONITIS;

ADULT; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LUPUS ERYTHEMATOSUS, SYSTEMIC; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PERITONITIS; PERITONITIS, TUBERCULOUS; RECURRENCE;

EID: 0036175456     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203302lu096cr     Document Type: Article

References (10)

1. Lupus nephritis: Classification, prognosis, immunopathogenesis, and treatment
2. End-stage renal disease and systemic lupus erythematosus
3. End-stage renal disease in lupus: Disease activity, dialysis, and the outcome of transplantation
4. Chronic infections and autoimmunity
5. The relationship between systemic lupus erythematosus and tuberculosis
6. Monoclonal anti-tuberculosis antibodies react with DNA and monoclonal anti-DNA autoantibodies react with Mycobacterium tuberculosis
7. Binding of monoclonal anti-DNA and anti-TB glycolipids to brain tissue
8. A common anti-DNA idiotype in sera of patients with active pulmonary tuberculosis
9. Rifampicin reduces effectiveness and bioavailability of prednisolone
10. Drug-induced lupus